Get started
Author

Sharon Caunt

Observed names: Caunt, Sharon, S. Caunt, SHARON CAUNT, Sharon Caunt (15212533), Sharon L Caunt
ORCID: 0000-0003-1479-8861
Observed ORCID: 0000-0003-1479-8861
OpenAlex ID: A5034728891
Home Waking Salivary Cortisone to Screen for Adrenal Insufficiency
2023 · Miguel Debono, Charlotte J. Elder, et al. · NEJM Evidence · 69
PDF
A prospective longitudinal study of Pasireotide in Nelson’s syndrome
2018 · Eleni Daniel, Miguel Debono, et al. · Pituitary · 31
PDF
Real world evidence supports waking salivary cortisone as a screening test for adrenal insufficiency
2023 · Miguel Debono, Sharon Caunt, et al. · Clinical Endocrinology · 20
PDF
Higher Sensory Cortical Energy Metabolism in Painful Diabetic Neuropathy: Evidence From a Cerebral Magnetic Resonance Spectroscopy Study
2023 · Gordon Sloan, Adriana Anton, et al. · Diabetes · 18
Evaluating a grant development public involvement funding scheme: a qualitative document analysis
2024 · Alexis Foster, Sharon Caunt, et al. · Research Involvement and Engagement · 17
PDF
Factors Influencing Physical Activity Level in Adults With Type 1 Diabetes: A Cross-Sectional Study
2024 · Rakel Fuglsang Johansen, Sharon Caunt, et al. · Canadian Journal of Diabetes · 16
Vascular and nerve biomarkers in thigh skin biopsies differentiate painful from painless diabetic peripheral neuropathy
2024 · Gordon Sloan, Philippe Donatien, et al. · Frontiers in Pain Research · 11
Increased Thalamocortical Functional Connectivity on Discontinuation of Treatment in Painful Diabetic Peripheral Neuropathy
2024 · Gordon Sloan, Kevin Teh, et al. · Diabetes · 9
PDF
A Cross-sectional Study on the Impact of Educational Status on Physical Activity Level in Danish and English Adults With Type 1 Diabetes
2024 · Sarah Elton Sander, Rakel Fuglsang Johansen, et al. · Canadian Journal of Diabetes · 5
Beyond pain relief: the effects of chronic opioid use on brain structure and function in diabetic neuropathy—a multimodal neuroimaging study
2025 · Gordon Sloan, Kevin Teh, et al. · Diabetologia · 3
PDF
Randomised, placebo-controlled, double-blinded, four-way crossover trial to demonstrate the comparative pharmacodynamic equivalence of a non-invasive diagnostic test for adrenal insufficiency in a healthy population: the STARLIT-2 study protocol
2024 · Kathryn L Date, Kathleen Baster, et al. · BMJ Open · 1
PDF
Waking salivary cortisone as screening test for adrenal insufficiency
2022 · Miguel Debono, Charlotte Elder, et al. · Endocrine Abstracts · 1
Thalamic neuronal and bioenergetic function in painful diabetic peripheral neuropathy: a dual magnetic resonance spectroscopy study
2026 · Gordon Sloan, Adriana Anton, et al. · Diabetologia
PDF
1458-P: Clinical Frailty Is a Major Determinant of Long-Term Survival in People with Diabetic Foot Ulcer Disease
2026 · NICOLA ANDRZEJOWSKA, MOHUMMAD SHAAN GOONOO, et al. · Diabetes
1119-OR: The Concurrent Validity of Abnormal DPNCheck for Confirmed Diabetic Peripheral Neuropathy: Time to Use This Screening Device in Routine Practice?
2026 · MOHUMMAD SHAAN GOONOO, DINESH SELVARAJAH, et al. · Diabetes
Higher disease burden and greater small fibre impairment in women with painful diabetic neuropathy
2026 · Gordon Sloan, Dinesh Selvarajah, et al. · PAIN Reports
Determining the comparative pharmacodynamic equivalence of a non-invasive diagnostic test for patients with adrenal insufficiency using a randomised 2-way crossover trial: the STARLIT-3 study protocol
2026 · Kathryn Date, Kathleen Baster, et al. · BMJ Open
PDF
User evaluation of the Hypo‐METRICS app: A tool for real‐time symptom reporting of hypoglycaemia
2025 · Monika Cigler, Uffe Søholm, et al. · Diabetic Medicine
PDF
Increased thalamocortical functional connectivity on discontinuation of treatment in painful diabetic peripheral neuropathy
2024 · Gordon Sloan, Kevin Teh, et al.
Increased thalamocortical functional connectivity on discontinuation of treatment in painful diabetic peripheral neuropathy
2024 · Gordon Sloan, Kevin Teh, et al.
PDF
The Sheffield one-stop enhanced diabetes care process screening for people with type 2 diabetes and intensified care for those with early nerve damage
2024 · Sharon Caunt, Solomon Tesfaye · http://isrctn.com/
OR30-01 Waking Salivary 11-hydroxyandrostenedione And Cortisone As A Novel Non-invasive Test For Adrenal Insufficiency
2023 · Neil Richard Lawrence, Brian George Keevil, et al. · Journal of the Endocrine Society
PDF
Higher sensory cortical energy metabolism in Painful-Diabetic Neuropathy: evidence from a cerebral Magnetic Resonance Spectroscopy study
2023 · Gordon Sloan, Adriana Anton, et al.
Higher sensory cortical energy metabolism in Painful-Diabetic Neuropathy: evidence from a cerebral Magnetic Resonance Spectroscopy study
2023 · Gordon Sloan, Adriana Anton, et al.
PDF
Screening for adrenal insufficiency using home waking salivary cortisone is accurate and lowers NHS costs
2022 · Miguel Debono, Charlotte Elder, et al. · Endocrine Abstracts
Works count: 31
Citation count: 201
H-index: 8
I10-index: 7
Year
Topic
Type